Transforming infectious disease research into a publication-ready manuscript
Overview
As a long-term medical writing partner, Morula Health has supported this client across numerous clinical and scientific documents. With no internal medical writing function, maintaining continuity was a key priority. By working with experienced writers who were already familiar with the client’s programs, stakeholder preferences, and document history, Morula Health was able to provide efficient, consistent support while preserving valuable program knowledge across projects.
For this project, Morula Health supported the development of a scientific manuscript based on a clinical study report (CSR) previously written by our team. The underlying real-world epidemiological study explored infectious diseases across key high-risk populations, with the findings being developed into a manuscript for submission to The Lancet.
Challenge
Turning a large epidemiological study into a publication-ready manuscript required a thoughtful approach to translating the depth of the CSR into a clear, focused publication. With input from multiple stakeholders, including an academic partner with specific preferences for the manuscript, the team worked collaboratively to align different perspectives, incorporate feedback and maintain momentum towards a high-quality final publication.
Solutions
Expert oversight from draft to review
Morula Health assigned an experienced medical writer who took an active role in managing the manuscript process. This helped the team navigate the different stakeholder perspectives and move the manuscript through the review process.
Flexibility as requirements evolved
As stakeholder requirements evolved, Morula Health adapted the drafting and review process accordingly, maintaining clear communication around scope and resourcing and using regular project status reporting to ensure transparency, alignment, and continued progress.
Continuity from CSR to publication
The project also benefited from continuity across documents. Having previously developed the CSR, Morula Health could support the next stage of communicating the study through a scientific manuscript. The scope also anticipated the realities of publication, with optional hours included for post-submission revisions or reformatting if required following journal review.
Results
The project demonstrated the value of combining experienced scientific writing with hands-on project management. Despite additional stakeholder complexity, the manuscript work progressed successfully, and client was very happy with how the project and writer transition were managed.
It also shows how continuity can extend beyond an individual document. Morula Health supported the underlying CSR and subsequently helped turn that work into a manuscript intended to bring the study findings into the public domain.
Feel confident in your clinical and regulatory documents
Get in touch to discuss how our experienced team and Medical Writers can support you.
Our work
Accelerating Global AMR Research Program
Morula Health provided embedded medical writing support across a complex global antimicrobial resistance (AMR) program. By ensuring consistency across documents and applying deep infectious‑disease expertise, we enabled efficient delivery across multiple projects and regulatory touchpoints.
Find out more
AMR at a Turning Point: Key Insights from the BioInfect 2026 Conference
Last week, Morula Health attended BioInfect 2026, the annual infectious disease-focused event hosted by Bionow.
Find out more
Globalizing a China-Developed Asset: Rapid IB Update for FDA (US) and TGA (Australia) Submission
Morula Health was engaged to review and refine a translated IB to ensure alignment with Australian (TGA) and US (FDA) regulatory expectations and was suitable for submission.
Find out more